EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules

NICE has assessed the EarlyCDT Lung test for assessing solid lung nodules, to help the NHS decide whether to use it.

EarlyCDT Lung is a test that calculates the risk of lung cancer, but there isn’t much good evidence about how well it works and it is not clear how its use would affect decision making in the NHS. So NICE has said that EarlyCDT Lung should not be used to assess solid lung nodules and more research is needed.

ISBN: 978-1-4731-4453-8